Available Clinical Trials

Nevada Cancer Institute offers many diverse options for the treatment of cancer. For more information about any of the trials listed below, please contact the clinical researcher listed with each trial.

Solid Tumors
Solid Tumors and
Hematologic Malignancies

Breast Cancer
Non Small Cell Lung Cancer

Prostate
Urothelial Carcinoma

Return to Clinical Trials main

Solid Tumors

I/II

Goodman, Oscar

A Phase I/II, multi-center, open label study of BEZ235, administered orally on a continuous daily dosing schedule in adult patients with advanced solid malignancies including patients with advanced breast cancer

top ^

Solid Tumors and Hematologic Malignancies

Manno, Phillip

The Nevada Cancer Institute Clinical Data Research Protocol

top ^

Breast Cancer

Breast - Female	NA	Jacks, Karen	Prescriptive Exercise Intervention During Active Treatment for Early Stage Breast Cancer Patients: A Breast Cancer Rehabilitation & Exercise Laboratory
Breast - Female	III	Jacks, Karen	A randomized Phase III, double-blind, placebo-controlled multicenter trial of daily everolimus in combination with trastuzumab and vinorelbine, in pretreated women with HER2/neu over-expressing locally advanced or metastatic breast cancer
Breast - Female	III	Jacks, Karen	ALTTO: Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Study: A Randomized, Multi-Center, Open-Label, Phase III Study of Adjuvant Lapatinib, Trastuzumab, Their Sequence and Their Combination in Patients with HER2/ErbB2 Positive Primary Breast Cancer

top ^

Non Small Cell Lung Cancer

Non Small Cell Lung Cancer	II	Jacks, Karen	Phase II study of a triplet combination of CBP501, pemetrexed and cisplatin as first line treatment in patients with locally advanced (stage IIIB with malignant pleural effusion or pericardial effusion) or metastatic (stage IV) non-squamous non small cell lung cancer (NSCLC)
Non Small Cell Lung Cancer	III	Whitehead, Robert	A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer	III	Jacks, Karen	Randomized Phase III Trial of Gemcitabine/Carboplatin with or without BSI-201 (a PARP1 inhibitor) in patients with previously untreated advanced squamous cell lung cancer.

top ^

Prostate

Prostate	Biomarker Study	Goodman, Oscar	Analysis of circulating tumor cells in prostate cancer predicting response to taxanes
Prostate	III	Goodman, Oscar	A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone
Prostate	III	Goodman, Oscar	CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer
Prostate	III	Goodman, Oscar	A Randomized, Double-Blind, Phase III Trial to Compare the Efficacy of Ipilimumab vs.Placebo in Asymptomatic or Minimally Symptomatic Patients with Metastatic Chemotherapy-Nave Castration Resistant Prostate Cancer

top ^

Urothelial Carcinoma

Urothelial Carcinoma	II	Goodman, Oscar	A Phase II multi-center, non-randomized, open-label study of TKI258 in patients with either FGFR3 mutated or FGFR3 wild type advanced urothelial carcinoma
Urothelial Carcinoma	III	Goodman, Oscar	A Randomized Double-Blinded Phase III Study comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin and Placebo in Patients with Advanced Translational Cell Carcinoma

top ^